Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-
The quality of our products and the patient’s safety is our highest priority.
We ensure that our Quality Program is integrated into every stage of our products’ development, manufacture, warehousing, distribution and sales.
We produce and store our products under the highest quality standards, including those published by the U.S. FDA, European MDD as well as ISO 9001 and ISO 13485.
Our aim is to meet or exceed the highest quality standards by developing systems and technologies to implement through our quality management system.
All products qualified and released by Asepsis Medical Technologies’ quality control and assurance program undergo extensive release protocols.
Asepsis products offer Insta-track software integration, which allows our products to be tracked from our production sites to all distribution points.
Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021 – for the multi-dose oral Dose-2-Weight Syringe®. The Dose-2-Weight Sy
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-Dose® syringe provid
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intra
Asepsis announces the patent pending Safe-2-Dose™, the next generation liquid medication dispenser. The caregiver need only unlock the device and squeeze the bottle to obtain the correct amount of med